<?xml version="1.0" encoding="UTF-8"?>
<ref id="bibr56-1756286420932036">
 <label>56</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Brownlee</surname>
    <given-names>W</given-names>
   </name>
   <name>
    <surname>Bourdette</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Broadley</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Killestein</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Ciccarelli</surname>
    <given-names>O</given-names>
   </name>
  </person-group>
  <article-title>Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic</article-title>. [published online ahead of print, 2020 Apr 2]. 
  <source>Neurology</source>. 
  <year>2020</year>. doi: 
  <pub-id pub-id-type="doi">10.1212/WNL.0000000000009507</pub-id>.
 </mixed-citation>
</ref>
